INS and type 2 diabetes mellitus: Thiazolidinediones (TZDs) including troglitazone, pioglitazone, and rosiglitazone are synthetic PPAR γ ligands with the efficacy to enhance insulin sensitivity in animals and humans [14, 15], and some of the TZDs are already in clinical use as insulin sensitizers in type 2 diabetic patients [16].